Stably transfected common fragile site sequences exhibit instability at ectopic sites

Genes Chromosomes and Cancer

Volumn 47, Issue 10, 2008, Pages 860-872

  Ragland, Ryan L ^a   Glynn, Michael W ^a   Arlt, Martin F ^a   Glover, Thomas W ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN;

ARTICLE; CELL ISOLATION; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME REARRANGEMENT; CHROMOSOME REPLICATION; CONTROLLED STUDY; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACID ANHYDRIDE HYDROLASES; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN; DNA REPLICATION; GENOMIC LIBRARY; HCT116 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TRANSFECTION;

MAMMALIA;

EID: 50249178177     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20591     Document Type: Article

References (62)

1. Arlt MF, Miller DE, Beer DG, Glover TW. 2002. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 33:82-92.
2. Arlt MF, Xu B, Durkin SG, Casper AM, Kastan MB, Glover TW. 2004. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol 24:6701-6709.
3. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Schested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870.
4. Bednarck AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
5. Benson G. 1999. Tandem repeats finder: A program to analyze DNA sequences. Nucleic Acids Res 27:573-580.
6. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA. 1997. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 6:193-203.
7. Boldog FL, Waggoner B, Glover TW, Chumakov I, Le Paslier D, Cohen D, Gemmill RM, Drabkin HA. 1994. Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B. Genes Chromosomes Cancer 11:216-221.
8. Casper AM, Nghiem P, Arlt MF, Glover TW. 2002. ATR regulates fragile site stability. Cell 111:779-789.
9. Goquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplieons. Cell 89:215-225.
10. Goquelle A, Rozier L, Dutrillaux B, Debatisse M. 2002. Induction of multiple double-strand breaks within an hsr by meganucleaseI-SccI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements. Oncogene 21:7671-7679.
11. Corbin S, Neilly ME, Espinosa R, III, Davis EM, McKeithan TW, Le Beau MM. 2002. Identification of unstable sequences within the common fragile site at 3p14.2: Implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res 62:3477-3484.
12. Dayn A, Malkhosyan S, Duzhy D, Lyamichev V, Panchenko Y, Mirkin S. 1991. Formation of (dA-dT)n cruciforms in Escherichia coli cells under different environmental conditions. J Bacteriol 173:2658-2664.
13. Dunham MJ, Badrane H, Ferea T, Adams J, Brown PO, Rosenzweig F, Botstein D. 2002. Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 99:16144-16149.
14. Durkin SG, Glover TW. 2007. Chromosome fragile sites. Annu Rev Genet 41:169-192.
15. Durkin SG, Arlt MF, Howlett NG, Glover TW. 2006. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25:4381-1388.
16. Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, Glover TW. 2008. Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci USA 105:246-251.
17. Elder FF, Robinson TJ. 1989. Rodent common fragile sites: Are they conserved? Evidence from mouse and rat. Chromosoma 97:459-464.
18. Ferber MJ, Eilers P, Schuuring E, Fenton JA, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AA. 2004. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 154:1-9.
19. Finnis M, Davan S, Hobson L, Chenevix-Trench G, Friend K, Ried K, Venter D, Woollatt E, Baker E, Richards RI. 2005. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet 14:1341-1349.
20. Focarelli ML, Montagna C, Colombo R, Ried T, Vezzoni P, Musio A. 2006. SMC1 inhibition results in FRA3B expression but has no effect on its delayed replication. Mutat Res 595:23-28.
21. Glover TW, Stein CK. 1987. Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet 41:882-890.
22. Glover TW, Stein CK. 1988. Chromosome breakage and recombination at fragile sites. Am J Hum Genet 43:265-273.
23. Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG. 1998. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res 58:3409-3414.
24. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Eiloglou T, Venere M, Ditullio RA, Jr. Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913.
25. Hellman A, Rahat A, Scherer SW, Darvasi A, Tsui LC, Kerem B. 2000. Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol 20:4420-4427.
26. Helmrich A, Stout-Weider K, Hermann K, Schrock E, Heiden T. 2006. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes. Genome Res 16:1222-1230.
27. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. 2005. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 14:693-701.
28. Huebner K, Croce CM. 2003. Cancer and the FRA3B/FHIT fragile locus: It's a HIT. Br J Cancer 88:1501-1506.
29. Kim SY, Horrigan SK, Altenhofen JL, Arbieva ZH, Hoffman R, Westbrook CA. 1998. Modification of bacterial artificial chromosome clones using Cre recombinase: Introduction of selectable markers for expression in eukaryotic cells. Genome Res 8:404-412.
30. Kuo MT, Vyas RC, Jiang LX, Hittelman WN. 1994. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 14:5202-5211.
31. Le Beau MM, Rassool FV, Neilly ME, Espinosa R, III, Glover TW, Smith DI, McKeithan TW. 1998. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: Implications for the mechanism of fragile site induction. Hum Mol Genet 7:755-761.
32. Lemoine FJ, Degtyareva NP, Lobachev K, Petes TD. 2005. Chromosomal translocations in yeast induced by low levels of DNA polymerase a model for chromosome fragile sites. Cell 120:587-598.
33. Limongi MZ, Pelliceia F, Rocchi A. 2003. Characterization of the human common fragile site FRA2G. Genomics 81:93-97.
34. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
35. McAllister BF, Greenbaum IF. 1997. How common are common fragile sites: Variation of aphidicolin-induced chromosomal fragile sites in a population of the deer mouse (Peromyscus maniculatus). Hum Genet 100:182-188.
36. Michael D, Beer DG, Wilke CW, Miller DE, Glover TW. 1997. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene 15:1653-1659.
37. Mirkin EV, Mirkin SM. 2007. Replication fork stalling at natural impediments. Microbiol Mol Biol Rev 71:13-35.
38. Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H, Platzer M, Weiss A, Tsui LC, Rosenthal A, Kerem B. 1998. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci USA 95:8141-8146.
39. Musio A, Montagna C, Mariani T, Tilenni M, Focarelli ML, Brait L, Indino E, Benedetti PA, Chessa L, Albertini A, Ried T, Vezzoni P. 2005. SMC1 involvement in fragile site expression. Hum Mol Genet 14:525-533.
40. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
41. Palakodeti A, Han Y, Jiang Y, Le Beau MM. 2004. The role of late/slow replication of the FRA16D in common fragile site induction. Genes Chromosomes Cancer 39:71-76.
42. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R, III, Le Beau MM. 1991. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: An approach to cloning fragile sites. Proc Natl Acad Sci USA 88:6657-6661.
43. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. 2000. Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663.
44. Roeder GS, Fink GR. 1980. DNA rearrangements associated with a transposable element in yeast. Cell 21:239-249.
45. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene 23:6872-6880.
46. Ruiz-Herrera A, Garcia F, Fronicke L, Ponsa M, Egozcue J, Caldes MG, Stanyon R. 2004. Conservation of aphidicolin-induced fragile sites in Papionini (Primates) species and humans. Chromosome Res 12:683-690.
47. Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, le Sage C, Chen BP, Chen DJ, Agami R, Kerem B. 2005. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev 19:2715-2726.
48. Shiraishi T, Druck T, Mimori K, Flomenberg J, Berk L, Alder H, Miller W, Huebner K, Croce CM. 2001. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit. Proc Natl Acad Sci USA 98:5722-5727.
49. Smeets DF, van de Klundert FA. 1990. Common fragile sites in man and three closely related primate species. Cytogenet Cell Genet 53:8-14.
50. Soulie J, De Grouchy J. 1981. A cytogenetic survey of 110 baboons (Papio cynocephalus). Am J Phys Anthropol 56:107-113.
51. Stone DM, Jacky PB, Hancock DD, Prieur DJ. 1991. Chromosomal fragile site expression in dogs: I. Breed specific differences. Am J Med Genet 40:214-222.
52. Sutherland GR. 2003. Rare fragile sites. Cytogenet Genome Res 100:77-84.
53. Tsantoulis PK, Kotsinas A, Sfikakis PP, Evangelou K, Sideridou M, Levy B, Mo L, Kittas C, Wu XR, Papavassiliou AG, Gorgoulis VG. 2008. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genomewide study. Oncogene 27:3256-3264.
54. Wang L, Darling J, Zhang JS, Huang H, Liu W, Smith DI. 1999. Allele-specific late replication and fragility of the most active common fragile site, FRA3B. Hum Mol Genet 8:431-437.
55. Wang ND, Testa JR, Smith DI. 1993. Determination of the specificity of aphidicolin-induced breakage of the human 3p14.2 fragile site. Genomics 17:341-347.
56. Wang Z, Engler P, Longacre A, Storb U. 2001. An efficient method for high-fidelity BAC/PAC retrofitting with a selectable marker for mammalian cell transfection. Genome Res 11:137-142.
57. Warburton PE, Giordano J, Cheung F, Gelfand Y, Benson G. 2004. Inverted repeat structure of the human genome: The X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes. Genome Res 14:1861-1869.
58. Wilke CM, Guo SW, Hall BK, Boldog F, Gemmill RM, Chandrasekharappa SC, Barcroft CL, Drabkin HA, Glover TW. 1994. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics 22:319-326.
59. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. 1996. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187-195.
60. Wilson K. 2001. Preparation of genomic DNA from bacteria. Curr Protoc Mol Biol Chapter 2:Unit 2.4.
61. Zhang H, Freudenreich CH. 2007. An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. Mol Cell 27:367-379.
62. Zhu M, Weiss RS. 2007. Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells. Mol Biol Cell 18:1044-1055.